Mayne Pharma Group Ltd. | Cash Flow
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
21,290.00
7,537.00
34,523.00
86,026.00
134,257.00
Depreciation, Depletion & Amortization
9,859.00
13,502.00
21,377.00
73,668.00
79,883.00
Other Funds
-
-
-
4,841.00
-
Funds from Operations
29,300.00
17,598.00
33,294.00
169,995.00
157,047.00
Changes in Working Capital
3,164.00
4,822.00
20,210.00
185,232.00
35,549.00
Net Operating Cash Flow
26,136.00
22,420.00
53,504.00
15,237.00
121,498.00
Capital Expenditures
35,296.00
83,603.00
62,848.00
1,083,922.00
94,337.00
Sale of Fixed Assets & Businesses
-
996.00
-
806.00
-
Purchase/Sale of Investments
-
966.00
-
-
486.00
Net Investing Cash Flow
50,814.00
95,504.00
83,798.00
1,096,991.00
118,413.00
Issuance/Reduction of Debt, Net
2,408.00
1,094.00
13,337.00
-
-
Net Financing Cash Flow
19,886.00
115,109.00
17,990.00
1,128,859.00
20,243.00
Net Change in Cash
5,018.00
44,457.00
11,709.00
15,546.00
24,285.00
Free Cash Flow
21,933.00
18,246.00
23,914.00
119,653.00
67,317.00
Deferred Taxes & Investment Tax Credit
374.00
6,358.00
25,684.00
32,598.00
163.00
Net Assets from Acquisitions
821.00
-
-
-
173.00
Change in Capital Stock
17,478.00
114,015.00
4,653.00
863,781.00
1,526.00
Exchange Rate Effect
226.00
2,432.00
595.00
1,085.00
957.00
Other Uses
14,697.00
11,931.00
20,950.00
13,875.00
23,417.00
About Mayne Pharma Group
View Profile
